FIELD: medicine.
SUBSTANCE: invention refers to a method of evaluating the damaging action of protein p53 on placenta in acute herpes virus infection. The method consists in evaluating protein p53 and a herpes virus antibody titre by EIA method in placenta homogenate. The herpes virus antibody titre 1:12800 and protein p53 4.52±0.16 E/ml ensure to observe higher risk of damaging morphofunctional condition of syncytiotrophoblast.
EFFECT: method exhibits high sensitivity and allows predicting damaging placenta syncytiotrophoblast in acute herpes virus infection in the pregnancy.
Authors
Dates
2010-05-27—Published
2009-05-26—Filed